RELM a Mouse

RELM-alpha Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

Tissue Distribution and Expression

RELM-alpha is predominantly expressed in macrophages and epithelial cells, with tissue-specific regulation:

  • Adipose Tissue: Highest constitutive expression in stromal vascular cells, not adipocytes .

  • Macrophages: Expressed by small peritoneal, alveolar, and adipose tissue macrophages; induced by IL-4 and IL-13 .

  • Intestinal Epithelium: Limited expression in healthy intestine but upregulated in parasitic infections .

  • Lung Epithelial Cells: Induced by Oncostatin M (OSM) during inflammation, contributing to extracellular matrix remodeling .

TissueExpression LevelKey Triggers
Small Peritoneal MacrophagesHigh (constitutive)Basal, IL-4, IL-13
Adipose TissueHigh (stromal cells)Basal
Lung Epithelial CellsModerate to HighOSM, Th2 inflammation
Intestinal EpitheliumLow (basal); High (infection)Parasites (e.g., Schistosoma)

Biological Functions

RELM-alpha modulates immune responses and tissue repair through distinct mechanisms:

  • Macrophage Polarization: A hallmark of M2 macrophages (alternatively activated macrophages) .

  • Th2 Cytokine Regulation: Inhibits Th2 cytokine production (e.g., IL-4, IL-5, IL-13) via Bruton’s tyrosine kinase (Btk)-dependent pathways .

  • Parasite Infection: Elevated during parasitic infections (e.g., Schistosoma mansoni) to limit inflammation .

  • Fibrosis: Promotes extracellular matrix remodeling by inducing collagen synthesis (COL1A1, COL3A1) and myofibroblast differentiation .

Key Pathways:

  • Anti-Inflammatory: Limits Th2-driven inflammation and granuloma formation .

  • Pro-Fibrotic: Enhances tissue repair but may exacerbate fibrosis in chronic inflammation .

Research Applications and Tools

RELM-alpha is studied using specialized reagents and techniques:

Recombinant Proteins

  • Source: Produced in E. coli (non-glycosylated) .

  • Applications:

    • Functional studies (e.g., inhibition of Th2 cytokines) .

    • Standardization in ELISA or Western blotting .

Antibodies

  • DS8RELM (Thermo Fisher):

    • Target: Mouse RELM-alpha protein.

    • Applications: Flow cytometry (intracellular staining), immunophenotyping of macrophages .

    • Optimal Use: Requires permeabilization buffers for intracellular detection .

  • Polyclonal Anti-RELMα (Leinco):

    • Target: Mouse RELM-alpha.

    • Applications: Western blotting (detection limit: 2 ng/lane) .

ReagentTypeApplicationSensitivity
DS8RELM (Clone)MonoclonalFlow cytometryMedium to high signal
Anti-RELMα (Polyclonal)PolyclonalWestern blotting2 ng/lane

Key Research Findings

  1. Role in Th2 Inflammation:

    • Retnla−/− mice show exacerbated lung inflammation and fibrosis after Schistosoma infection, with increased Th2 cytokines and granuloma size .

    • Recombinant RELM-alpha binds macrophages and Th2 cells, suppressing IL-4/IL-5/IL-13 production .

  2. Interaction with Human Resistin:

    • Human resistin (homolog of mouse RELM-alpha) is upregulated in lung inflammatory cells and shares functional similarities in hypoxia and inflammation .

  3. Regulation by OSM:

    • Oncostatin M induces RELM-alpha expression in airway epithelial cells, promoting CD206+ M2 macrophage accumulation and extracellular matrix remodeling .

Clinical and Therapeutic Implications

  • Parasitic Infections: RELM-alpha may serve as a biomarker for parasitic infections .

  • Fibrosis: Targeting RELM-alpha pathways could modulate fibrotic diseases (e.g., pulmonary fibrosis) .

  • Allergic Disorders: Potential therapeutic target in Th2-driven allergies .

Product Specs

Introduction
Bronchoalveolar lavage fluid obtained from mice experiencing experimentally induced allergic pulmonary inflammation has been found to contain a previously unidentified 9.4 kDa cysteine-rich secreted protein known as RELM-alpha (FIZZ1, found in inflammatory zone). This protein is primarily found within the stroma of adipose tissue. Murine RELM-alpha (FIZZ1) is recognized as the first member of a newly identified gene family. This family includes two other murine genes, one expressed in intestinal crypt epithelium (RELM-beta) and the other in white adipose tissue (Resistin), as well as two related human genes.
Description
Recombinant Mouse RELM-alpha, produced in E. coli, is a monomeric polypeptide chain that lacks glycosylation. It comprises 88 amino acids, resulting in a molecular weight of 10 kDa. The purification of Mouse RELM-alpha is achieved through proprietary chromatographic methods.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
The product undergoes sterile filtration and lyophilization from a solution of 0.5mg/ml in 10mM sodium phosphate buffer with a pH of 7.5.
Solubility
It can be reconstituted to a concentration of 0.1mg/ml in deionized sterile water.
Stability
For long-term storage, the lyophilized protein should be kept at -20°C. To minimize degradation caused by repeated freezing and thawing, it is recommended to aliquot the product after reconstitution. The reconstituted protein remains stable at 4°C for a limited period; no changes are observed within two weeks of storage at this temperature.
Purity
The purity of the protein is determined to be greater than 98% through SDS-PAGE and RP-HPLC analysis.
Synonyms
Resistin-like alpha, RELMalpha, Cysteine-rich secreted protein FIZZ1, Parasite-induced macrophage novel gene 1 protein, Cysteine-rich secreted protein A12-gamma, RELM-a.
Source
Escherichia Coli.
Amino Acid Sequence
MDETIEIIVE NKVKELLANP ANYPSTVTKT LSCTSVKTMN RWASCPAGMT ATGCACGFAC GSWEIQSGDT CNCLCLLVDW TTARCCQLS.

Q&A

What is RELM-alpha and what is its biological significance in mouse models?

RELM-alpha (also known as Retnla, FIZZ1, or Resistin-like alpha) is a secreted protein belonging to the resistin/FIZZ family that functions as a hallmark signature gene for alternatively activated macrophages. It is highly induced by allergic inflammatory triggers and plays critical roles in parasite infection, mucosal inflammation, and allergy responses . The highest constitutive expression has been observed in small peritoneal macrophages, alveolar macrophages, and adipose tissue macrophages .

RELM-alpha is strongly induced by IL-4 and IL-13, and together with Arginase 1 and Ym-1, is considered one of the hallmarks of M2 polarization of mouse macrophages. Importantly, macrophages polarized with IL-10 (M2c) do not express either RELM-alpha or Arginase 1, highlighting its specificity as a marker for certain M2 subtypes . Functionally, RELM-alpha likely acts as a hormone and plays a documented role in pulmonary vascular remodeling .

How does RELM-alpha expression vary across different mouse macrophage populations?

RELM-alpha expression exhibits significant heterogeneity across macrophage populations, which is critical to consider when designing experiments:

Table 1: RELM-alpha expression in different macrophage populations

Macrophage PopulationConstitutive RELM-alpha ExpressionResponse to IL-4/IL-13 Stimulation
Small Peritoneal MacrophagesHighFurther increased
Alveolar MacrophagesHighFurther increased
Adipose Tissue MacrophagesHighFurther increased
Large Peritoneal MacrophagesLittle to noneStrongly induced
M2a Polarized MacrophagesN/AStrongly induced
M2c Polarized Macrophages (IL-10)NoneNot induced
Lymphoid CellsNoneNone

The highest level of constitutive expression has been observed in Small Peritoneal Macrophages. In contrast, Large Peritoneal Macrophages express little or no RELM-alpha unless stimulated . The expression level of RELM-alpha is considered medium to high compared to bright markers like CD4 or CD8 .

What markers should be used alongside RELM-alpha in macrophage polarization studies?

When studying macrophage polarization in mouse models, RELM-alpha should be included in panels with complementary markers to fully characterize macrophage phenotypes:

Table 2: Recommended markers for use with RELM-alpha in flow cytometry panels

MarkerPurposeRelevance to RELM-alpha
CD11bPan-myeloid markerIdentifies macrophage populations
F4/80Macrophage markerIdentifies mature macrophages
Arginase 1M2 polarization markerCo-expressed with RELM-alpha in M2a macrophages
Ym-1M2 polarization markerCo-expressed with RELM-alpha in M2a macrophages
CD206 (Mannose Receptor)M2 polarization markerHelps distinguish M2 subsets
iNOSM1 polarization markerHelps distinguish from M1 macrophages
CD80/CD86M1 activation markersHelps distinguish from M1 macrophages
IL-4RαIL-4 receptorRequired for RELM-alpha induction

These markers can be effectively combined in flow cytometry panels to characterize the complete polarization state of macrophages. For optimal results when studying RELM-alpha, the Intracellular Fixation & Permeabilization Buffer set is recommended as it works best with the DS8RELM clone .

What are the key differences between mouse RELM-alpha and human resistin?

Understanding the relationship between mouse RELM-alpha and its human counterparts is crucial for translational research:

Table 3: Comparison of mouse RELM-alpha and human resistin

FeatureMouse RELM-alphaHuman Resistin
GeneRetnlaRETN
Amino Acid Length111 amino acids108 amino acids
Primary Expressing CellsAlternatively activated macrophagesMacrophages and monocytes
InductionIL-4, IL-13Inflammatory stimuli
FunctionTissue repair, parasite responseInflammatory signaling
Role in MetabolismIndirectDirect role in insulin resistance
HomologyN/AResembles mouse RELM-alpha in sequence, tissue distribution, and function

Humans lack a direct RELM-alpha ortholog, but human Resistin shares functional and structural similarities. This distinction is critical when designing studies with translational implications .

What experimental approaches are most effective for studying RELM-alpha in disease models?

When investigating RELM-alpha in disease contexts, several experimental approaches have proven effective:

  • Genetic manipulation: The Velocigene technology has been successfully employed to generate Retnla−/− mice by replacing the genomic Retnla with a LacZ neoexpression cassette . These knockout models allow investigation of RELM-alpha's role in various disease conditions.

  • Induced disease models: For inflammatory conditions, the dextran sodium sulfate (DSS)–induced colitis model has been well-established for studying RELM-alpha's role in intestinal inflammation .

  • Ex vivo culture systems: Supernatants from ex vivo colon cultures can be assessed for cytokine production, and LPS-stimulated macrophages can be incubated with recombinant RELM-alpha to evaluate its immunomodulatory effects .

  • In vivo administration: Intraperitoneal administration of recombinant RELM-alpha can be used to assess cellular recruitment to the peritoneum, providing insights into its chemoattractant properties .

  • Flow cytometry combined with intracellular staining: This approach allows for the simultaneous detection of RELM-alpha with other markers to characterize macrophage populations. The DS8RELM antibody clone works effectively with the Intracellular Fixation & Permeabilization Buffer set .

  • PrimeFlow RNA Assay: This technique enables detection of RELM-alpha mRNA, which can be valuable for comparing transcriptional and translational regulation .

  • Bead-based multiplex assays: These can be used to simultaneously measure RELM-alpha along with other cytokines and chemokines in biological samples.

How can I optimize flow cytometry protocols for RELM-alpha detection in mouse tissues?

Optimizing flow cytometry for RELM-alpha detection requires careful attention to several experimental parameters:

Table 4: Optimization parameters for RELM-alpha flow cytometry

ParameterRecommendationRationale
Fixation & PermeabilizationUse Intracellular Fixation & Permeabilization Buffer SetClone DS8RELM works best with this buffer system
Antibody CloneDS8RELMSpecifically validated for flow cytometry applications
Fluorophore SelectionConsider PE conjugates for medium-expressed markersRELM-alpha expression is medium to high compared to bright markers like CD4/CD8
Control SamplesInclude unstimulated cells and IL-4 stimulated cellsProvides baseline and positive control for induction
Block Fc ReceptorsInclude Fc block in staining protocolReduces non-specific binding
Viability DyeInclude fixable viability dyeEnsures analysis of only viable cells
CompensationUse single-stained controlsCritical for multi-parameter panels
Gating StrategyGate on CD11b+ cells firstRELM-alpha is primarily expressed in myeloid cells

For reliable detection of RELM-alpha in macrophages, a recommended approach is to:

  • Isolate cells from tissue of interest

  • Block Fc receptors

  • Stain for surface markers

  • Fix and permeabilize cells using the Intracellular Fixation & Permeabilization Buffer Set

  • Stain with anti-RELM-alpha (clone DS8RELM) antibody

  • Analyze CD11b positive cells for RELM-alpha expression

This protocol can be complemented with PrimeFlow RNA Assay to detect RELM-alpha mRNA as a validation approach .

What methodological considerations are crucial when generating and validating Retnla−/− mouse models?

When generating and validating Retnla−/− mouse models, several methodological considerations are essential:

  • Generation technique: The Velocigene technology has been successfully used to delete genomic Retnla by replacing it with a LacZ neoexpression cassette .

  • Genotyping protocol: PCR analysis using specific primers is recommended:

    • Relm-α forward: GTCAGCAATCCCATGGCGTA

    • Relm-α reverse: ACTTCCCTACCCACCCATTCC

    • Lac-Z: GTCTGTCCTAGCTTCCTCACTG

    This yields an 800-bp band for wild-type mice and a 400-bp band for gene-targeted mice .

  • Backcrossing requirements: To ensure genetic homogeneity, backcrossing to the desired strain (e.g., C57BL/6 or BALB/c) for at least 7-10 generations is recommended .

  • Validation of gene deletion: Measuring serum levels of Relm-α protein using ELISA is an effective approach to confirm the absence of RELM-alpha in knockout mice .

  • Control selection: Wild-type mice should be environmentally matched with the Retnla−/− mice for 2-3 weeks before experiments to minimize non-genetic variables .

  • Housing conditions: All mice should be housed under specific pathogen-free conditions to prevent inflammatory activation that might influence RELM-alpha expression .

  • Age and sex matching: Use 8- to 12-week-old mice of the same sex for experiments to control for developmental and hormonal variables .

  • Specificity controls: Including Retnlb−/− mice as additional controls can help verify the specificity of RELM-alpha deletion, as these mice should still express RELM-alpha .

How do environmental factors affect RELM-alpha expression in laboratory mice?

Environmental factors significantly influence RELM-alpha expression in laboratory mice, which can impact experimental reproducibility:

  • Pathogen exposure: Laboratory mice should be maintained under specific pathogen-free conditions, as pathogen exposure, particularly parasitic infections, can dramatically elevate RELM-alpha levels .

  • Housing conditions: Environmental enrichment, cage density, and bedding type can all influence stress levels and subsequently affect immune parameters including RELM-alpha expression.

  • Diet composition: Dietary components, particularly fat content, can influence adipose tissue macrophages, which are high expressors of RELM-alpha .

  • Microbiome variation: Gut microbiota composition affects intestinal immune responses and can modulate RELM-alpha expression in gut-associated macrophages.

  • Circadian rhythm: Time of day when samples are collected may influence RELM-alpha levels due to circadian regulation of immune parameters.

  • Stress factors: Handling, noise, and other stressors can alter immune cell activation status and potentially impact RELM-alpha expression.

  • Age-related changes: Developmental stage and aging affect macrophage polarization states and RELM-alpha expression patterns.

Following the principles of the 3Rs (Replacement, Refinement, and Reduction) for animal research not only promotes ethical animal use but also ensures more robust and reproducible results in RELM-alpha studies .

What are the best practices for experimental design when studying RELM-alpha-dependent pathways?

When designing experiments to investigate RELM-alpha-dependent pathways, several best practices should be followed:

  • Include proper controls: Use appropriate wild-type controls that are environmentally matched with experimental mice for 2-3 weeks before experiments .

  • Utilize multiple approaches: Combine genetic approaches (such as Retnla−/− mice) with recombinant protein administration or neutralizing antibodies to validate findings through complementary methods .

  • Consider tissue-specific expression: Design tissue collection protocols that target known high-expression sites of RELM-alpha, such as small peritoneal macrophages, alveolar macrophages, and adipose tissue macrophages .

  • Account for strain differences: Be aware that background strain can influence RELM-alpha expression and responses. Studies have successfully used both C57BL/6 and BALB/c backgrounds for Retnla−/− mice .

  • Validate antibodies: Confirm specificity of anti-RELM-alpha antibodies using Retnla−/− samples as negative controls .

  • Consider temporal dynamics: Design time-course experiments to capture the dynamic regulation of RELM-alpha, particularly following IL-4/IL-13 stimulation .

  • Standardize stimulation protocols: For in vitro studies, standardize the concentration and duration of IL-4/IL-13 stimulation to ensure reproducible RELM-alpha induction .

  • Biological replicates: Remember that despite genetic similarity, inbred mice remain biological entities that show phenotypic variability. Design experiments with sufficient biological replicates (distinct mice) rather than technical replicates .

  • Document environmental conditions: Record and report housing conditions, diet, and other environmental factors that might influence RELM-alpha expression .

How can I troubleshoot contradictory RELM-alpha expression data across experiments?

When facing contradictory RELM-alpha expression data across experiments, systematic troubleshooting is essential:

Table 5: Common challenges and solutions in RELM-alpha research

ChallengePossible CausesTroubleshooting Approach
Inconsistent RELM-alpha detection by flow cytometryInadequate fixation/permeabilizationOptimize protocol using the Intracellular Fixation & Permeabilization Buffer Set
Variable baseline expression in untreated samplesEnvironmental or pathogen exposureMaintain strict SPF conditions; environmentally match controls and experimental groups
Discrepancies between mRNA and protein levelsPost-transcriptional regulationCombine PrimeFlow RNA Assay with protein detection to examine both levels
Strain-dependent differencesGenetic background effectsEnsure consistent genetic background; document strain used in all reports
Age-related variabilityDevelopmental changes in immune systemStrictly age-match experimental animals; document age in methods
Contradictory results between in vitro and in vivo studiesComplex in vivo environmentValidate in vitro findings using multiple in vivo approaches
Antibody specificity issuesCross-reactivity with other RELM family membersValidate antibody specificity using Retnla−/− samples

Remember that mice, despite being genetically identical within a strain, are biological entities that show phenotypic variability, are sensitive to environmental factors, and change developmentally over time . These factors can contribute to experimental variability and should be carefully controlled and documented.

Product Science Overview

Discovery and Nomenclature

RELM-alpha was first discovered in 2000 by Holcomb et al. in bronchoalveolar lavage fluid from mice with experimentally induced allergic pulmonary inflammation . Due to its discovery in various tissues and diseases, RELM-alpha has several synonyms, including Cysteine-rich secreted protein A12-γ and Parasite-induced macrophage novel gene 1 protein .

Structure and Expression

RELM-alpha is a highly cysteine-rich protein, characterized by a conserved C-terminal domain with 10 cysteine residues arranged in a unique spacing motif . In mice, RELM-alpha is predominantly secreted by adipocytes, while in humans, its expression is more varied .

Biological Functions

RELM-alpha plays a crucial role in various physiological and pathological processes, including:

  • Inflammatory Response: It is involved in the regulation of inflammation, particularly in lung and intestinal tissues .
  • Cell Proliferation: RELM-alpha influences the proliferation of lung cells .
  • Glucose Metabolism: It has a role in glucose metabolism, impacting energy homeostasis .
  • Barrier Defense: RELM-alpha contributes to the defense mechanisms of skin and colon barriers .
Signaling Pathways

RELM-alpha mediates several signaling pathways, including:

  • HMGB1/RAGE Pathway
  • IL-4/IL-4Rα Pathway
  • PI3K/Akt/mTOR Pathway

These pathways are critical for its involvement in inflammatory responses, cell proliferation, and glucose metabolism.

Clinical Relevance

RELM-alpha is associated with the progression of multiple diseases, such as:

  • Lung Diseases: It is implicated in various pulmonary conditions, including asthma and chronic obstructive pulmonary disease (COPD) .
  • Intestinal Diseases: RELM-alpha plays a role in inflammatory bowel diseases (IBD) like Crohn’s disease and ulcerative colitis .
  • Cardiovascular Diseases: It is involved in the pathogenesis of cardiovascular conditions .
  • Cancers: RELM-alpha has been linked to the development and progression of certain cancers .
Recombinant Production

Recombinant RELM-alpha from mice is typically expressed in E. coli and purified to high levels of purity (≥98%) using techniques like SDS-PAGE and HPLC . The recombinant protein is a monomeric protein with a molecular weight of approximately 10.0 kDa and contains 88 amino acid residues .

Applications

Recombinant RELM-alpha is used in various research applications to study its biological functions and potential therapeutic targets. It serves as a valuable tool for understanding the mechanisms underlying its role in inflammation, metabolism, and disease progression .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.